Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 17

1.
2.

Breast cancer and ovarian cancer genetics.

Edlich RF, Winters KL, Lin KY.

J Long Term Eff Med Implants. 2005;15(5):533-45. Review.

PMID:
16218901
3.

Hereditary breast cancer. Risk assessment of patients with a family history of breast cancer.

Warner E, Heisey RE, Goel V, Carroll JC, McCready DR.

Can Fam Physician. 1999 Jan;45:104-12. Review.

4.

[Screening for breast cancer on basis of individual risk assessment for women ineligible for the national population screening program].

van Asperen CJ, de Bock GH, van der Horst F, de Koning HJ, Rutgers EJ.

Ned Tijdschr Geneeskd. 2001 Jan 20;145(3):120-5. Review. Dutch.

PMID:
11206121
5.

Screening and follow-up of the patient at high risk for breast cancer.

Willey SC, Cocilovo C.

Obstet Gynecol. 2007 Dec;110(6):1404-16. Review.

PMID:
18055740
6.

[Breast cancer screening different from that used for the general population: who is concerned and with which approach?].

Chappuis PO.

Rev Med Suisse. 2006 May 17;2(66):1296-8, 1301-2, 1304-5. Review. French.

PMID:
16775990
7.

Screening for breast and ovarian cancer: the relevance of family history.

Pharoah PD, Stratton JF, Mackay J.

Br Med Bull. 1998;54(4):823-38. Review.

8.

Breast cancer risk perception and surveillance: an integrative review.

Martin W, Lobchuk M.

Online J Knowl Synth Nurs. 2003 May 28;10:2. Review.

PMID:
12800051
9.

A role for biomarkers in the screening and diagnosis of breast cancer in younger women.

Esserman LJ, Shieh Y, Park JW, Ozanne EM.

Expert Rev Mol Diagn. 2007 Sep;7(5):533-44. Review.

PMID:
17892362
10.

Improving the referral process for familial breast cancer genetic counselling: findings of three randomised controlled trials of two interventions.

Wilson BJ, Torrance N, Mollison J, Wordsworth S, Gray JR, Haites NE, Grant A, Campbell MK, Miedyzbrodzka Z, Clarke A, Watson MS, Douglas A.

Health Technol Assess. 2005 Feb;9(3):iii-iv, 1-126. Review.

11.

The role of magnetic resonance imaging in screening women at high risk of breast cancer.

Warner E.

Top Magn Reson Imaging. 2008 Jun;19(3):163-9. doi: 10.1097/RMR.0b013e31818bc994. Review.

PMID:
18941396
12.

Epidemiology, genetics, and risk evaluation of postmenopausal women at risk of breast cancer.

Vogel VG.

Menopause. 2008 Jul-Aug;15(4 Suppl):782-9. doi: 10.1097/gme.0b013e3181788d88. Review.

PMID:
18596599
13.

A systematic review of the effectiveness of magnetic resonance imaging (MRI) as an addition to mammography and ultrasound in screening young women at high risk of breast cancer.

Lord SJ, Lei W, Craft P, Cawson JN, Morris I, Walleser S, Griffiths A, Parker S, Houssami N.

Eur J Cancer. 2007 Sep;43(13):1905-17. Epub 2007 Aug 2. Review.

PMID:
17681781
14.

Systematic review: using magnetic resonance imaging to screen women at high risk for breast cancer.

Warner E, Messersmith H, Causer P, Eisen A, Shumak R, Plewes D.

Ann Intern Med. 2008 May 6;148(9):671-9. Review.

PMID:
18458280
15.

Breast cancer: who is at risk?

Lucassen A, Houlston R.

Practitioner. 1997 Dec;241(1581):757-9, 762. Review. No abstract available.

PMID:
9926607
16.

Familial breast cancer: is it time to move from a reactive to a proactive role?

Harris H, Nippert I, Julian-Reynier C, Schmidtke J, van Asperen C, Gadzicki D, Tibben A, Evans DG.

Fam Cancer. 2011 Sep;10(3):501-3. doi: 10.1007/s10689-011-9434-1. Review.

PMID:
21400222
17.

The family history as a screening tool.

Stroop JB.

Pediatr Ann. 2000 May;29(5):279-82. Review. No abstract available.

PMID:
10826322
Items per page

Supplemental Content

Write to the Help Desk